SEAGULL HEALTH
Your health,We care!
Orelabrutinib can precisely inhibit the proliferation, survival and migration of malignant B cells, and is featured by strong targeting ability and favorable safety profile.
AuthenticGuaranteeFast DeliveryPrivacy indication1、 Adult patients with mantle cell lymphoma (MCL) who have received at least one treatment in the past.2、 Adult patients with chronic lympho···【Read More】
Update: 23 Sep,2026Source: Haiou HealthViews: 95
Beijing, China, April 25, 2025 – InnoCare Pharma, a high-tech biopharmaceutical company, announced that its independently developed novel Bruton's···【Read More】
Update: 22 Jan,2026Source: Haiou HealthViews: 180
Beijing, China, April 20, 2023 – InnoCare Pharma, a high-tech biopharmaceutical company, announced that its independently developed novel Bruton's···【Read More】
Update: 22 Jan,2026Source: Haiou HealthViews: 183
Beijing, China – December 31, 2020 – InnoCare Pharma, a high-tech biopharmaceutical company, announced that its independently developed Bruton's t···【Read More】
Update: 22 Jan,2026Source: Haiou HealthViews: 154
Beijing, China, December 27, 2020 – InnoCare Pharma (Hong Kong Stock Exchange: 09969), a high-tech biopharmaceutical company, announced today that its···【Read More】
Update: 22 Jan,2026Source: Haiou HealthViews: 156
Copyright 2024 @ haiouhealth.com All right reserved Seagull health | Bigbear Pharmaceutical | Lucius Pharmaceuticals | 老挝全球药房
